| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |